The Clorox Company (NYSE:CLX) Shares Sold by Anchor Investment Management LLC

Anchor Investment Management LLC trimmed its stake in The Clorox Company (NYSE:CLX) by 2.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,188 shares of the company’s stock after selling 259 shares during the quarter. Anchor Investment Management LLC’s holdings in Clorox were worth $1,660,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp increased its holdings in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after buying an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC raised its holdings in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the period. Geode Capital Management LLC lifted its stake in shares of Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after purchasing an additional 33,970 shares in the last quarter. Stifel Financial Corp grew its holdings in shares of Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after purchasing an additional 37,967 shares during the period. Finally, Nuance Investments LLC increased its position in Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $164.68 on Friday. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $20.38 billion, a price-to-earnings ratio of 57.38, a price-to-earnings-growth ratio of 3.08 and a beta of 0.42. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The business has a 50 day simple moving average of $163.63 and a 200-day simple moving average of $151.21.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the company earned $0.49 earnings per share. The business’s revenue was up 27.0% compared to the same quarter last year. As a group, equities research analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 2.96%. Clorox’s dividend payout ratio is presently 170.03%.

Analyst Ratings Changes

Several equities analysts recently weighed in on CLX shares. DA Davidson lifted their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. JPMorgan Chase & Co. raised their target price on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Barclays upped their price target on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Citigroup boosted their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Five equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Clorox presently has an average rating of “Hold” and an average target price of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.